| Market Cap | 360.18M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -64.84M | Forward P/E | -7.57 | EPS next Y | 19.80% | 50D Avg Chg | 31.00% |
| Sales | 229.75M | PEG | 0.94 | EPS past 5Y | - | 200D Avg Chg | 30.00% |
| Dividend | N/A | Price/Book | 1.29 | EPS next 5Y | -5.20% | 52W High Chg | -30.00% |
| Recommedations | 1.60 | Quick Ratio | 1.56 | Shares Outstanding | 37.76M | 52W Low Chg | 74.00% |
| Insider Own | 9.65% | ROA | -9.53% | Shares Float | 31.13M | Beta | 1.39 |
| Inst Own | 72.72% | ROE | -21.57% | Shares Shorted/Prior | 339.49K/396.44K | Price | 9.54 |
| Gross Margin | 61.77% | Profit Margin | -28.22% | Avg. Volume | 268,945 | Target Price | 15.81 |
| Oper. Margin | -25.35% | Earnings Date | Mar 9 | Volume | 1,161,199 | Change | 8.29% |
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.
| Truist Securities | Hold | Nov 2, 22 |
| Piper Sandler | Overweight | Aug 3, 22 |
| Truist Securities | Buy | Jul 20, 22 |
| Stifel | Buy | Mar 14, 22 |
| Piper Sandler | Overweight | Mar 14, 22 |
| Truist Securities | Buy | Dec 21, 21 |
| Canaccord Genuity | Buy | May 4, 21 |
| Wells Fargo | Overweight | Apr 8, 21 |
| Canaccord Genuity | Buy | Mar 2, 21 |